Comparison of different immunoassays for CA 19-9

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 12, 2001, Pages 1278-1282

  Stern, P ^a   Friedecky, B ^a   Bartos, V ^a   Bezdickova, D ^a   Vavrova, J ^a   Uhrova, J ^a   Rozprimova, L ^a   Zima, T ^a   Palicka, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CA 19 9 immunoassays; Comparability; Evidence based medicine; Repeatability

Indexed keywords

CA 19-9 ANTIGEN; MONOCLONAL ANTIBODY;

ANALYTIC METHOD; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REGRESSION ANALYSIS; REPRODUCIBILITY; STANDARDIZATION;

CA-19-9 ANTIGEN; HUMANS; IMMUNOENZYME TECHNIQUES; LINEAR MODELS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035664398     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.205     Document Type: Article

References (16)

1. Chromatographic characterization of CA 19-9 molecules from cystic fibrosis and pancreatic carcinoma
2. Reliability of the immunoassay measurement of tumor markers
3. European symposium on clinical laboratory and in vitro diagnostics industry
4. Evidence-based medicine: How to practise and teach EBM
5. The science of systematic reviewing studies of diagnostics tests
6. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests
7. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I
8. Statistical methods for assessing agreement between two methods of clinical measurement
9. Current databases on biological variation: Pros, cons and progress
10. Immunoassay standardization: Is it possible, who is responsible, who is capable?